During the past decade, CH AUCH conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "CH AUCH" #1 sponsor was "Institut Claudius Regaud" with 3 trials, followed by "Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer" with 2 trials sponsored, "University Hospital, Grenoble" with 2 trials sponsored, "Centre Hospitalier Departemental Vendee" with 1 trials sponsored and "Floralis" with 1 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "CH AUCH" #1 collaborator was "Centre Hospitalier Universitaire de Saint Etienne" with 1 trials as a collaborator, "Centre Hospitalier Universitaire, Amiens" with 1 trials as a collaborator, "Floralis" with 1 trials as a collaborator, "Groupe Francophone Thrombose et Cancer (GFTC)" with 1 trials as a collaborator and "Investigation network on venous thrombo-embolism" with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "CH AUCH" are "Deep Vein Thrombosis" (2 trials), "Breast Ductal Carcinoma In Situ" (1 trials), "Covid19" (1 trials), "Embolism and Thrombosis" (1 trials) and "HER2-positive Breast Cancer" (1 trials). Many other conditions were trialed in "CH AUCH" in a lesser frequency.

Most popular intervention types in "CH AUCH" are "Other" (8 trials), "Drug" (2 trials), "Diagnostic Test" (1 trials), "Dietary Supplement" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "2 FES-PET Imaging will be performed:" (1 trials), "AMA (Assistance for ambulatory patients)" (1 trials), "Anastrozole" (1 trials), "CREDO standard of care" (1 trials) and "Color Doppler Ultrasound" (1 trials). Other intervention names were less common.

The vast majority of trials in "CH AUCH" are 10 trials for "All" genders and 4 trials for "Female" genders.

Currently, there are NaN active trials in "CH AUCH". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in CH AUCH, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in CH AUCH, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 5 trials that are defined as “Not Applicable".